Rebion’s Blinq. Device for pediatric vision screening
“There is something terribly wrong with the status quo when half of the children with amblyopia go undetected and untreated before school age”
Overview
Blinq. is the first FDA approved vision screening device that doesn’t just predict risk — it detects amblyopia and strabismus directly.
In just seconds, blinq uses patented Neural Performance Scanning™ to assess how both eyes work together, giving clinicians and parents an objective, science-backed result: pass or refer.
Because when it comes to a child’s sight, early detection isn’t just helpful — it’s life-changing.
Check out the device in action below, and click through the site to see how Blinq. supports parents, clinicians, high-volume screeners, and schools.
